Saturday, May 21, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Policy + Initiatives

Obama Signs Pandemics and All-Hazards Preparedness Act of 2013

by Global Biodefense Staff
March 14, 2013

Pandemic PreparednessThe Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA) of 2013 was signed into law yesterday by President Barack Obama. The legislation reauthorizes provisions of the Project Bioshield Act of 2004 and the Pandemic and All-Hazards Preparedness Act (PAHPA) of 2006 for an additional five years.

The law extends the mandate of the Biomedical Advanced Research and Development Authority (BARDA) to support medical countermeasure development for biothreat agents for possible inclusion in the U.S. Strategic National Stockpile. PAHPRA also enhances the authority of the U.S. Food and Drug Administration to support rapid responses to public health emergencies by clarifying that even before an event, FDA may issue an emergency use authorization to allow emergency use of certain products as medical countermeasures.

PAHPRA also provides funding for a variety of public health and medical preparedness programs. “With the reauthorization, communities can continue to count on our National Disaster Medical System, now more than 7,000 personnel strong, to bring medical professionals from across the country to provide care and support hospitals, shelters, and communities after a disaster,” stated Assistant Secretary Nicole Lurie from the U.S. Department of Health and Human Services.

The act grants new authorities to state health departments for more flexibility in dedicating resources to meet critical community needs in a disaster. States may now choose to temporarily deploy federally funded state personnel whose day-to-day jobs are not related directly to emergencies, to meet immediate urgent needs. For example, staff paid through HIV grant funding could be deployed for a short term to provide care for the public during a pandemic.

The Congressional Budget Office estimated implementation of the bill will cost $11 billion between fiscal years 2014 to 2018.

Tags: BARDAPandemicStrategic National Stockpile

Related Posts

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster
Preparedness

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

May 6, 2022
Congenital Syphilis Continues a Decade-Long Surge Across the US
Infectious Diseases

Congenital Syphilis Continues a Decade-Long Surge Across the US

April 12, 2022
Troubling Trends in Physician Vaccine Confidence in the United States
Medical Countermeasures

Troubling Trends in Physician Vaccine Confidence in the United States

April 5, 2022
Will Omicron Be More Contagious Than Delta?
Biosecurity

U.S. Government to Conduct Sweeping Review of Biosecurity Policy Frameworks

February 28, 2022
Load More

Latest News

NIH to Further Invest in Point-of-Care Technologies Research Network

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022

How a COVID-19 Infection Spurs Antibodies Against Common Colds

May 8, 2022
Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

May 6, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC